Cargando…

Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study

Sepsis is the result of an uncontrolled host inflammatory response to infection that may lead to septic shock with multiorgan failure and a high mortality rate. There is an urgent need to improve early diagnosis and to find markers identifying those who will develop septic shock and certainly a need...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banoei, Mohammad M., McIntyre, Lauralyn A., Stewart, Duncan J., Mei, Shirley H. J., Courtman, David, Watpool, Irene, Granton, John, Marshall, John, dos Santos, Claudia, Walley, Keith R., Schlosser, Kenny, Fergusson, Dean A., Winston, Brent W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673547/ https://www.ncbi.nlm.nih.gov/pubmed/37999238 http://dx.doi.org/10.3390/metabo13111142

Ejemplares similares

Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients*
por: Schlosser, Kenny, et al.
Publicado: (2019)

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
por: Lalu, Manoj M., et al.
Publicado: (2012)

A survey of Canadian intensivists' resuscitation practices in early septic shock
por: McIntyre, Lauralyn A, et al.
Publicado: (2007)

Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
por: Thompson, Mary, et al.
Publicado: (2020)

Customized Internal Reference Controls for Improved Assessment of Circulating MicroRNAs in Disease
por: Schlosser, Kenny, et al.
Publicado: (2015)

Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
por: Lalu, Manoj M, et al.
Publicado: (2016)

High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice
por: Schlosser, Kenny, et al.
Publicado: (2018)

Lack of elevation in plasma levels of pro-inflammatory cytokines in common rodent models of pulmonary arterial hypertension: questions of construct validity for human patients
por: Schlosser, Kenny, et al.
Publicado: (2017)

Multicountry survey of emergency and critical care medicine physicians’ fluid resuscitation practices for adult patients with early septic shock
por: McIntyre, Lauralyn, et al.
Publicado: (2016)

Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers
por: Schlosser, Kenny, et al.
Publicado: (2016)

Thawed Mesenchymal Stem Cell Product Shows Comparable Immunomodulatory Potency to Cultured Cells In Vitro and in Polymicrobial Septic Animals
por: Tan, Yuan, et al.
Publicado: (2019)

Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
por: Mehta, Sangeeta, et al.
Publicado: (2013)

Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
por: Mehta, Sangeeta, et al.
Publicado: (2017)

Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients
por: Souza-Moreira, Luciana, et al.
Publicado: (2022)

Albumin in early septic shock resuscitation: examination of plasma and urine inflammatory markers
por: Fox-Robichaud, A, et al.
Publicado: (2012)

Results of the cellular immuno-therapy for covid-19 related acute respiratory distress syndrome (circa-phase i trial
por: English, S., et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cells: PRELIMINARY RESULTS FOR THE CELLULAR IMMUNO-THERAPY FOR COVID-19-RELATED ARDS MULTICENTRE CANADIAN RANDOMIZED CLINICAL TRIAL: CIRCA-19 PHASE 2 RCT
por: Stewart, D.J., et al.
Publicado: (2023)

The conundrum of persistent inappropriate use of frozen plasma
por: Tinmouth, Alan T, et al.
Publicado: (2011)

Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol
por: Suen, Colin M., et al.
Publicado: (2016)

Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock
por: Russell, James A., et al.
Publicado: (2019)

The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research
por: Avey, Marc T., et al.
Publicado: (2016)

Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
por: Lalu, Manoj M, et al.
Publicado: (2014)

Significance of lactate clearance in septic shock patients with high bilirubin levels
por: Takahashi, Nozomi, et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL
por: Khan, S., et al.
Publicado: (2023)

The role of endotoxin in septic shock
por: Kellum, John A., et al.
Publicado: (2023)

Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review
por: McIntyre, Lauralyn A., et al.
Publicado: (2016)

Hyperchloremia and moderate increase in serum chloride are associated with acute kidney injury in severe sepsis and septic shock patients
por: Suetrong, Bandarn, et al.
Publicado: (2016)

Saline versus albumin fluid for extracorporeal removal with slow low-efficiency dialysis (SAFER-SLED): study protocol for a pilot trial
por: Clark, Edward G., et al.
Publicado: (2019)

Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review
por: Suen, Colin M., et al.
Publicado: (2019)

Pro/con clinical debate: Are steroids useful in the management of patients with septic shock?
por: Ritacca, Frank V, et al.
Publicado: (2002)

Red blood cell transfusion and mortality effect in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis protocol
por: English, Shane W, et al.
Publicado: (2015)

Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
por: Barron, Carly C., et al.
Publicado: (2017)

Septic Shock
por: Kim, Kyuseok, et al.
Publicado: (2018)

Refractory septic shock: our pragmatic approach
por: Nandhabalan, Prashanth, et al.
Publicado: (2018)

Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study)
por: Clark, Edward G., et al.
Publicado: (2021)

Endotoxic Septic Shock: Diagnosis and Treatment
por: Foster, Debra M., et al.
Publicado: (2023)

Risk Factors for Septic Shock After Irinotecan-Containing Chemotherapy: An Exploratory Case-Control Study
por: Umemiya, Maki, et al.
Publicado: (2022)

Mottling reduction in the early phases of profound septic shock
por: Taylor, Daniel, et al.
Publicado: (2019)

Subarachnoid hemorrhage admissions retrospectively identified using a prediction model
por: English, Shane W., et al.
Publicado: (2016)

Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials: ATTENTION: The analysis and conclusions of this article are being revised by the authors. This is due to the journal Anesthesia and Analgesia's retraction of a paper by Dr. Joachim Boldt, an author in seven of the studies analyzed in this review. As such, the editors of Open Medicine recommend interpreting this review with extreme caution until Zarychanski et al. publish a new analysis and interpretation in Open Medicine. For more information, see Anesthesia and Analgesia's press release.
por: Zarychanski, Ryan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7q07obc2fbp94pecvvebrmpr12